Canada markets close in 6 hours 11 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
29.20+0.42 (+1.46%)
As of 09:48AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close28.78
Open29.37
Bid29.08 x 400
Ask29.40 x 400
Day's Range29.15 - 29.76
52 Week Range17.53 - 45.58
Volume38,106
Avg. Volume1,162,153
Market Cap4.243B
Beta (5Y Monthly)0.70
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Insider Monkey

    Should You Hold Immunovant (IMVT)?

    Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

  • Zacks

    Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

    Immunovant's (IMVT) late-stage studies evaluating its lead candidate, batoclimab, for various autoimmune indications are progressing well. Several data readouts are expected in 2024 and 2025.

  • Zacks

    What Makes Immunovant (IMVT) a New Buy Stock

    Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).